Talking Points

C. Michael Gibson and Holger Thiele take a deep dive into a head-to-head trial of TAVR devices that also considered general versus local anesthesia.

C. Michael Gibson talks with Patrick Serruys about, TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population."

C. Michael Gibson and Hiroki Shiomi look at long-term outcomes from RESET.

C. Michael Gibson and Lars Sondergaard discuss 1-year outcomes in the PORTICO I trial.

Does timing of an atorvastatin loading dose make a difference in PCI for ACS? C. Michael Gibson and Renato Lopes discuss.

C. Michael Gibson, Kenneth Rosenfield, and Robert Lookstein discuss the way forward for PERT.

C. Michael Gibson and Jörg Hausleiter discuss the TRIVALVE trial.

C. Michael Gibson and Clemens von Birgelen discuss the BIONYX randomized trial.

C. Michael Gibson and Pieter Stella discuss ReCre8, which evaluated a polymer-free DES in an all-comers population.

What do you get when you combine Twitter and a textbook? C. Michael Gibson talks with Michael Savage and David Fischman.